Search results
Results from the WOW.Com Content Network
State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access to Novo Nordisk's Wegovy or Eli Lilly's Zepbound, according to the ...
Medicaid beneficiaries in North Carolina will soon be able to get GLP-1 drugs like Wegovy, Saxenda and Zepbound covered. NC Medicaid to cover weight-loss drugs like Wegovy, after access cut for ...
But beginning Jan. 1, Halstead's federal Blue Cross Blue Shield health insurance plan is changing coverage for glucagon-like peptide 1 (GLP-1) drugs such as Wegovy and Ozempic.
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden ...
End of rebate ends savings. In 2023, the health plan received a 40% rebate from Novo Nordisk, the manufacturer of Wegovy and Saxenda, according to an analysis by State Health Plan staff.
Medicare covers Wegovy as a treatment to reduce the risk of serious cardiovascular events in people who have overweight or obesity. It does not cover Wegovy for weight loss.
Medicare can pay for the popular weight-loss drug Wegovy — as long as the patients using it also have heart disease and need to reduce the risk of future heart attacks, strokes and other serious ...
Ending coverage of GLP-1s for weight loss, with an exception process. This would dramatically reduce the number of people taking the medications, which substantially reduces costs for the plan.